Evolutionary Genomics, Inc. (FNAM) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Evolutionary Genomics, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-2.00
Burn Risk
P/B Ratio
-2.87
Equity Deficit
Earnings Yield
-43.04%
Yield Gap
Profitability Health
2022Return on Equity
123.38%
Strong
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data
Growth Indicators
2022Revenue Growth
-
No data
Net Income Growth
30.74%
Strong
WeakModerateStrong
EPS Growth
32.69%
Strong
WeakModerateStrong
Efficiency & Liquidity
2022Current Ratio
3.92
Strong
WeakModerateStrong
Quick Ratio
3.92
Strong
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-14.26%
Weak
WeakModerateStrong
EV / Free Cash Flow
-11.96x
Strong
WeakModerateStrong
Net Debt / EBITDA
-3.47x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.961
Strong
WeakModerateStrong
Return on Invested Capital
-92.59%
Weak
WeakModerateStrong
Cash Conversion Cycle
-63.69 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for FNAM.
View Financial Statements